Consensus Documents American College of Cardiology Foundation Task Force on Clinical Expert Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the

[1]  D. Forman,et al.  Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. , 2010, The Cochrane database of systematic reviews.

[2]  Therese Miller,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[3]  N. Abraham,et al.  National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti‐inflammatory drug use , 2008, Alimentary pharmacology & therapeutics.

[4]  Deepak L. Bhatt,et al.  Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis , 2008, The Lancet.

[5]  J. Hirsh,et al.  Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[6]  G. Guyatt,et al.  Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[7]  M. Fromm,et al.  Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.

[8]  Peter J. Richardson,et al.  Effectiveness of National Provider Prescription of PPI Gastroprotection Among Elderly NSAID Users , 2008, The American Journal of Gastroenterology.

[9]  Dominique Mottier,et al.  Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.

[10]  R. Califf,et al.  Initial Aspirin Dose and Outcome Among ST-Elevation Myocardial Infarction Patients Treated With Fibrinolytic Therapy , 2008, Circulation.

[11]  Christopher E. Buller,et al.  2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.

[12]  Deepak L. Bhatt.  Intensifying platelet inhibition--navigating between Scylla and Charybdis. , 2007, The New England journal of medicine.

[13]  M. Bulsara,et al.  Predictive and Protective Factors Associated With Upper Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Case-Control Study , 2007, The American Journal of Gastroenterology.

[14]  W. Chey,et al.  American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection , 2007, The American Journal of Gastroenterology.

[15]  S. Yusuf,et al.  Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. , 2007, The New England journal of medicine.

[16]  J. Hirsh,et al.  Combined antiplatelet and anticoagulant therapy: clinical benefits and risks , 2007, Journal of thrombosis and haemostasis : JTH.

[17]  A. Fendrick,et al.  Summing the risk of NSAID therapy , 2007, The Lancet.

[18]  H. El‐Serag,et al.  Cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident , 2007, Alimentary pharmacology & therapeutics.

[19]  E. Antman,et al.  Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. , 2007, Circulation.

[20]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[21]  Á. Lanas,et al.  Effect of Antisecretory Drugs and Nitrates on the Risk of Ulcer Bleeding Associated With Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, and Anticoagulants , 2007, The American Journal of Gastroenterology.

[22]  D. Moliterno,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[23]  C. Hawkey,et al.  Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies , 2007, Arthritis research & therapy.

[24]  Á. Lanas,et al.  Low-dose aspirin and upper gastrointestinal damage:epidemiology, prevention and treatment , 2007, Current medical research and opinion.

[25]  Mark J. Eisenberg,et al.  Drug-Eluting Stents: The Price Is Not Right , 2006, Circulation.

[26]  S. Hernández-Díaz,et al.  Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications , 2006, BMC Medicine.

[27]  J. Hallas,et al.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study , 2006, BMJ : British Medical Journal.

[28]  D. Morgan,et al.  The Burden of Gastrointestinal and Liver Diseases, 2006 , 2006, The American Journal of Gastroenterology.

[29]  L. Laine,et al.  Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. , 2006, The American journal of medicine.

[30]  K. Chu,et al.  Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  Deepak L. Bhatt.  NSAIDS and the risk of myocardial infarction: do they help or harm? , 2006, European heart journal.

[32]  Á. Lanas,et al.  Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations , 2006, Gut.

[33]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[34]  M. Parikh,et al.  Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. , 2006, The Journal of invasive cardiology.

[35]  F. Chan,et al.  Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors , 2006, The American Journal of Gastroenterology.

[36]  G. Biondi-Zoccai,et al.  Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. , 2006, European heart journal.

[37]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[38]  C. Hawkey,et al.  Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin , 2005, Alimentary pharmacology & therapeutics.

[39]  L. Laine,et al.  Bleeding complications related to aspirin dose. , 2005, The American journal of cardiology.

[40]  Joseph Loscalzo,et al.  Cyclooxygenase inhibition and cardiovascular risk. , 2005, Circulation.

[41]  R. Knill-Jones,et al.  Upper gastrointestinal haemorrhage associated with low‐dose aspirin and anti‐thrombotic drugs – a 6‐year analysis and comparison with non‐steroidal anti‐inflammatory drugs , 2005, Alimentary pharmacology & therapeutics.

[42]  Deepak L. Bhatt,et al.  Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. , 2005, The American journal of cardiology.

[43]  S. Yusuf,et al.  Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. , 2005, JAMA.

[44]  V. Wong,et al.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. , 2005, The New England journal of medicine.

[45]  Bidan Huang,et al.  Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. , 2004, Clinical therapeutics.

[46]  J. Fries,et al.  The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[47]  R. Blumenthal,et al.  A practical and evidence-based approach to cardiovascular disease risk reduction. , 2004, Archives of internal medicine.

[48]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[49]  M. Frisse,et al.  Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users. , 2004, Archives of internal medicine.

[50]  F. Chan,et al.  Prevention of non‐steroidal anti‐inflammatory drug gastrointestinal complications – review and recommendations based on risk assessment , 2004, Alimentary pharmacology & therapeutics.

[51]  Constance K Haan,et al.  Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Circulation.

[52]  S. Yusuf,et al.  Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[53]  Á. Lanas,et al.  Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs , 2003, European journal of gastroenterology & hepatology.

[54]  Á. Lanas,et al.  Low Frequency of Upper Gastrointestinal Complications in a Cohort of High-Risk Patients Taking Low-Dose Aspirin or NSAIDS and Omeprazole , 2003, Scandinavian journal of gastroenterology.

[55]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[56]  K. Chu,et al.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. , 2002, The New England journal of medicine.

[57]  D. Faigel,et al.  Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. , 2002, Gastrointestinal endoscopy.

[58]  P. Romano,et al.  Endoscopic Evidence of Mucosal Injury in Patients Taking Ticlopidine Compared With Patients Taking Aspirin/Nonsteroidal Antiinflammatory Drugs and Controls , 2002, Journal of clinical gastroenterology.

[59]  P. Shekelle,et al.  A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. , 2002, The Journal of rheumatology.

[60]  Á. Lanas,et al.  Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin , 2002, Alimentary pharmacology & therapeutics.

[61]  J. Atherton,et al.  Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding , 2002, Alimentary pharmacology & therapeutics.

[62]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[63]  Nina Singh,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[64]  R. Peto,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[65]  S. Hernández-Díaz,et al.  Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. , 2001, British journal of clinical pharmacology.

[66]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[67]  L. Ignarro,et al.  Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[68]  F. Chan,et al.  Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.

[69]  F. D. de Abajo,et al.  Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations , 2001, BMC clinical pharmacology.

[70]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[71]  Y. Loke,et al.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis , 2000, BMJ : British Medical Journal.

[72]  Á. Lanas,et al.  Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. , 2000, The New England journal of medicine.

[73]  J. Wallace,et al.  NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.

[74]  J. Olsen,et al.  Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin , 2000, American Journal of Gastroenterology.

[75]  Deepak L. Bhatt,et al.  Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. , 2000, American heart journal.

[76]  E. Toth,et al.  Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. , 2000, Scandinavian journal of gastroenterology.

[77]  A. Goddard,et al.  Low‐dose misoprostol for the prevention of low‐dose aspirin‐induced gastroduodenal injury , 2000, Alimentary pharmacology & therapeutics.

[78]  G. Triadafilopoulos,et al.  Epidemiology of NSAID induced gastrointestinal complications. , 1999, The Journal of rheumatology. Supplement.

[79]  C. Helmick,et al.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. , 1998, Arthritis and rheumatism.

[80]  S. Shapiro,et al.  Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product , 1996, The Lancet.

[81]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[82]  Salim Yusuf,et al.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials , 1996, BMJ.

[83]  J. Scheiman.  NSAIDs, gastrointestinal injury, and cytoprotection. , 1996, Gastroenterology clinics of North America.

[84]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[85]  A. Zinsmeister,et al.  Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly , 1995, Digestive Diseases and Sciences.

[86]  M. Rawlins,et al.  Prophylactic aspirin and risk of peptic ulcer bleeding , 1995, BMJ.

[87]  W. Ray,et al.  Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. , 1995, American journal of epidemiology.

[88]  V. Maxey,et al.  Striking prevalenceof over-thecounter nonsteroidal antiinflammatory drug use in patients with upper gastrointestinal hemorrhage: Wilcox CM, Shalek KA, Cotsonis G Arch Intern Med 154:42–46 Jan 1994 , 1994 .

[89]  C. Hawkey,et al.  Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin , 1992, Alimentary pharmacology & therapeutics.

[90]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[91]  C. Hawkey,et al.  Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine. , 1989, British journal of clinical pharmacology.

[92]  W. Schaffner,et al.  Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.

[93]  E. Antman,et al.  Scientific Statement From the American Heart Association Use of Nonsteroidal Antiinflammatory Drugs : An Update for Clinicians: A , 2007 .

[94]  D. Johnson.  Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist. , 2005, Reviews in cardiovascular medicine.

[95]  P. Teirstein,et al.  Effect of Combined Anticoagulation and Low-Dose Aspirin Treatment on Upper Gastrointestinal Bleeding , 2004, Digestive Diseases and Sciences.

[96]  F. Kabbinavar,et al.  Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[98]  L. E. Curtis,et al.  Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. , 1978, Gastroenterology.